CBD Surges into Mainstream with New Products, Celebrity Endorsements and Emerging Consensus about Benefits
HempWire Editorial Coverage: Analysts at Brightfield Group see CBD (cannabidiol) gobbling up a sizeable chunk of a projected $100 billion nutraceuticals 2022 U.S. market. Growing CBD market could eclipse broader cannabis market Consensus about health benefits backed by clinical work, personal endorsements lead to heightened interest CBD found in vast array of new products As CBD moves into the mainstream, opportunities are likely to grow exponentially for a variety of companies, including plant-based health and wellness product developer Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) (WLDFF Profile). Canadian company Tilray Inc. (NASDAQ: TLRY) is riding the wave by acquiring Manitoba Harvest,…